[go: up one dir, main page]

MA41558B1 - Compositions d'allergènes mélangés et leurs procédés d'utilisation - Google Patents

Compositions d'allergènes mélangés et leurs procédés d'utilisation

Info

Publication number
MA41558B1
MA41558B1 MA41558A MA41558A MA41558B1 MA 41558 B1 MA41558 B1 MA 41558B1 MA 41558 A MA41558 A MA 41558A MA 41558 A MA41558 A MA 41558A MA 41558 B1 MA41558 B1 MA 41558B1
Authority
MA
Morocco
Prior art keywords
allergen
mixed allergen
methods
mixed
allergen compositions
Prior art date
Application number
MA41558A
Other languages
English (en)
Other versions
MA41558A (fr
Inventor
Kari C Nadeau
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41558(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MA41558A publication Critical patent/MA41558A/fr
Publication of MA41558B1 publication Critical patent/MA41558B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pulmonology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)

Abstract

L'invention concerne des compositions d'allergènes mélangés de deux ou de plus de deux allergènes différents. Dans certains cas, les compositions d'allergènes mélangés comprennent : un allergène à base de noix, un allergène à base d'animal ; et au moins un élément parmi : un allergène de plante autre que type noix ; un agent biotique ; et une vitamine. L'invention concerne également des procédés d'administration des compositions d'allergènes mélangés à un sujet. Les compositions d'allergènes mélangés trouvent une utilisation dans un grand nombre d'applications, notamment le maintien de la santé, l'équilibre immunitaire, l'équilibre digestif, le soutien immunitaire, l'amélioration de la santé, et des applications thérapeutiques.
MA41558A 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation MA41558B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
PCT/US2016/018731 WO2016134291A2 (fr) 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
MA41558A MA41558A (fr) 2017-12-26
MA41558B1 true MA41558B1 (fr) 2023-02-28

Family

ID=56689334

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41558A MA41558B1 (fr) 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation

Country Status (21)

Country Link
US (4) US10064936B2 (fr)
EP (2) EP4186521A1 (fr)
JP (3) JP6859261B2 (fr)
KR (2) KR20240148968A (fr)
CN (2) CN114129720B (fr)
AU (2) AU2016219793C1 (fr)
CA (1) CA2977127A1 (fr)
DK (1) DK3258962T3 (fr)
ES (1) ES2937287T3 (fr)
FI (1) FI3258962T3 (fr)
HU (1) HUE061576T2 (fr)
IL (1) IL253976B2 (fr)
LT (1) LT3258962T (fr)
MA (1) MA41558B1 (fr)
MX (2) MX393928B (fr)
PL (1) PL3258962T3 (fr)
PT (1) PT3258962T (fr)
RS (1) RS63941B1 (fr)
SG (2) SG10201909093XA (fr)
SI (1) SI3258962T1 (fr)
WO (1) WO2016134291A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
DK3258962T3 (da) 2015-02-20 2023-02-06 Univ Leland Stanford Junior Blandede allergensammensætninger og fremgangsmåde til anvendelse af disse
WO2016138030A2 (fr) * 2015-02-23 2016-09-01 Antera Therapeutics Inc. Compositions et procédés induisant la tolérance du système immunitaire à des allergènes
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
CA3043747A1 (fr) * 2016-11-21 2018-05-24 Before Brands, Inc. Compositions d'allergenes liquides et leurs procedes de fabrication
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
SG10201913846XA (en) * 2017-01-13 2020-03-30 Aimmune Therapeutics Inc Methods of manufacture of nut flours and formulations for oral immunotherapy
FR3062797B1 (fr) 2017-02-10 2025-03-07 Centre Hospitalier Et Univ De Clermont Ferrand Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
EP3654778A1 (fr) * 2017-07-18 2020-05-27 Before Brands, Inc. Procédés de fabrication de compositions d'allergènes mixtes
WO2019112808A1 (fr) 2017-12-06 2019-06-13 Prollergy Corporation Composition et procédé pour la réduction de la réaction allergique
EP3836801A4 (fr) * 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. Immunothérapie orale de désensibilisation à l'arachide avec dose d'entretien
MX2021006366A (es) * 2018-11-30 2021-10-13 Alladapt Immunotherapeutics Inc Metodos para hacer composiciones alergenicas mixtas.
AU2019410757B2 (en) * 2018-12-21 2025-05-15 Société des Produits Nestlé S.A. Drinkable infant compositions
US20220072123A1 (en) * 2019-01-10 2022-03-10 Before Brands, Inc. Methods of introducing food allergens
AU2020213085A1 (en) 2019-01-23 2021-08-12 Société des Produits Nestlé S.A. Methods for making mixed allergen compositions
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
WO2022185284A1 (fr) * 2021-03-05 2022-09-09 Société des Produits Nestlé S.A. Procédés de fabrication et d'évaluation de compositions de noix allergènes
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder
CN117088950B (zh) * 2023-04-11 2025-02-07 西北农林科技大学 一种核桃低敏性复合物蛋白、制备方法及应用
CN117678739A (zh) * 2023-12-21 2024-03-12 唐楠 一种食物过敏原混合物及其制备方法和使用方法
KR102828054B1 (ko) * 2025-01-20 2025-07-01 최여름 이유식 첨가형 알러지 확인용 조성물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
US20020018778A1 (en) 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
AU2001263073A1 (en) 2000-05-12 2001-11-26 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (fr) 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
DE602004032025D1 (de) 2003-06-23 2011-05-12 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
US8491909B2 (en) 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
CN101394751A (zh) * 2006-02-27 2009-03-25 爱默思公司 包含坚果外壳的动物食物组合物
EP1872792A1 (fr) 2006-06-29 2008-01-02 Biotech Tools S.A. Méthode pour la production d'un allergène hydrolysé
CN101646418B (zh) * 2006-10-12 2013-07-17 昆士兰大学 调节免疫应答的组合物和方法
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
WO2009083589A1 (fr) 2008-01-02 2009-07-09 Biotech Tools S.A. Formulation pharmaceutique pour préparation d'allergènes
ES2585407T3 (es) 2008-02-01 2016-10-05 Murdoch Childrens Research Institute Un método para inducir tolerancia a un alérgeno
EP2140880B1 (fr) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification d'allergènes
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (ja) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 可溶性凝集体、免疫寛容誘導剤及びその製造方法
PT2467031E (pt) * 2009-08-18 2014-10-30 Nestec Sa Composição nutricional compreendendo estirpes lactococcus e redução de sintomas de alergia, especialmente em bebés e crianças
CN102596237A (zh) * 2009-09-07 2012-07-18 Dbv技术公司 治疗嗜酸细胞性食管炎的方法
CN102048077A (zh) * 2009-10-30 2011-05-11 梁振 一种方便营养果丁豆花
PT2563316T (pt) 2010-04-30 2019-05-27 Allovate Llc Pasta de dentes para desensibilização alérgica através da mucosa oral
US9724271B2 (en) * 2010-04-30 2017-08-08 Allovate, Llc Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
EA201390559A1 (ru) 2010-10-15 2013-08-30 Альк-Абелло А/С Подавление иммунного ответа по типу гиперчувствительности неродственным антигеном, получаемым из материала-источника аллергенов
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (zh) * 2012-12-11 2013-03-27 崔杰 一种花生核桃咸饼的制作方法
WO2014159609A1 (fr) 2013-03-14 2014-10-02 Allergen Research Corporation Préparations à base d'arachide et leurs utilisations
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
US20160030553A1 (en) 2013-03-19 2016-02-04 Biotech Tools S.A. Allergen preparation
CA2914037A1 (fr) 2013-06-06 2014-12-11 Anergis S.A. Peptides contigus se chevauchant pour le traitement d'une allergie aux acariens de la poussiere
US10485867B2 (en) * 2013-09-19 2019-11-26 Allovate, Llc Toothpaste for delivery of allergens to oral mucosa
EP2952200A1 (fr) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergène pour le traitement prophylactique d'une allergie
US11197896B2 (en) 2014-08-25 2021-12-14 Société des Produits Nestlé S.A. Egg protein formulations and methods of manufacture thereof
CN104273238A (zh) 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 一种芝麻酱干及其制备方法
DK3258962T3 (da) 2015-02-20 2023-02-06 Univ Leland Stanford Junior Blandede allergensammensætninger og fremgangsmåde til anvendelse af disse
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016138030A2 (fr) 2015-02-23 2016-09-01 Antera Therapeutics Inc. Compositions et procédés induisant la tolérance du système immunitaire à des allergènes

Also Published As

Publication number Publication date
HUE061576T2 (hu) 2023-07-28
KR20240148968A (ko) 2024-10-11
WO2016134291A3 (fr) 2016-10-13
EP3258962A2 (fr) 2017-12-27
SG11201706734SA (en) 2017-09-28
US20190038741A1 (en) 2019-02-07
SI3258962T1 (sl) 2023-07-31
MX2017010697A (es) 2017-11-17
LT3258962T (lt) 2023-02-27
US20160243217A1 (en) 2016-08-25
DK3258962T3 (da) 2023-02-06
US20220133882A1 (en) 2022-05-05
PL3258962T3 (pl) 2023-04-24
SG10201909093XA (en) 2019-11-28
US20170056494A1 (en) 2017-03-02
MA41558A (fr) 2017-12-26
FI3258962T3 (fi) 2023-04-12
CN114129720B (zh) 2025-01-07
WO2016134291A2 (fr) 2016-08-25
JP7509829B2 (ja) 2024-07-02
EP3258962B1 (fr) 2022-11-02
ES2937287T3 (es) 2023-03-27
IL253976A0 (en) 2017-10-31
RS63941B1 (sr) 2023-02-28
AU2016219793B2 (en) 2021-12-16
HK1247854A1 (en) 2018-10-05
JP2022125346A (ja) 2022-08-26
KR20170117562A (ko) 2017-10-23
MX2022008663A (es) 2022-08-10
IL253976B1 (en) 2024-05-01
AU2016219793A1 (en) 2017-08-31
IL253976B2 (en) 2024-09-01
EP3258962A4 (fr) 2018-07-11
JP6859261B2 (ja) 2021-04-14
JP2018505907A (ja) 2018-03-01
US10064936B2 (en) 2018-09-04
JP2021046445A (ja) 2021-03-25
NZ734525A (en) 2024-11-29
PT3258962T (pt) 2023-02-16
MX393928B (es) 2025-03-24
AU2016219793C1 (en) 2022-03-17
AU2022201699A1 (en) 2022-04-07
CN107405394A (zh) 2017-11-28
US9731003B2 (en) 2017-08-15
BR112017017894A2 (pt) 2018-04-10
EP4186521A1 (fr) 2023-05-31
CN114129720A (zh) 2022-03-04
AU2022201699B2 (en) 2025-04-10
CA2977127A1 (fr) 2016-08-25
CN107405394B (zh) 2021-12-14

Similar Documents

Publication Publication Date Title
MA41558B1 (fr) Compositions d'allergènes mélangés et leurs procédés d'utilisation
MA44312A (fr) Anticorps et leurs méthodes d'utilisation
MA51747A (fr) Formulation d'anticorps pharmaceutique à ph faible
EP4003369A4 (fr) Dérivé d'adénosine et composition pharmaceutique le comprenant
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
MA43187B1 (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
MA41265B1 (fr) Compositions pour administration de médicaments iléo-jéjunal.
WO2016060996A3 (fr) Compositions d'interleukine-15 et leurs utilisations
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
NO20070580L (no) Behandling av cancer.
EP3518971A4 (fr) Formulations thérapeutiques d'anticorps et de protéines et leurs utilisations
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
MA46685A (fr) Extrait d'une composition à base de plantes médicinales en tant qu'agent antimicrobien et/ou antibiofilm
FR3058059B1 (fr) Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine.
EP3908251A4 (fr) Compositions d'administration de produits pharmaceutiques et utilisations correspondantes
BR112018013084A2 (pt) tratamentos de combinação compreendendo a administração de imidazopirazinonas
WO2018094300A8 (fr) Protéines de liaison à un antigène anti-gitr et leurs procédés d'utilisation
EP3389602A4 (fr) Compositions de soin buccal comprenant au moins un copolymère d'acrylate/phosphate et au moins un principe actif cationique
SV2003000712A (es) Dispositivos y metodos para aplicacion vertida ref. 497363sv:ssi
FR3086172B1 (fr) Formulation cosmetique
MA49948A (fr) Compositions pharmaceutiques et schémas posologiques contenant des anticorps anti-alpha (v) bêta (6)
MA41102A (fr) Compositions contenant de la curcumine à biodisponibilité améliorée
EP4023647A4 (fr) Dérivé d'imidazopyridine et composition pharmaceutique le comprenant en tant que principe actif
FR3036616B1 (fr) Principe actif cosmetique sous forme de gel comprenant au moins une argile a structure feuilletee et des acides alpha-hydroxiques, et compositions cosmetiques le comprenant.